Área de prevención cardiovascular y rehabilitación cardiaca
National Institute of Allergy and Infectious Diseases
Bethesda, Estados UnidosPublicaciones en colaboración con investigadores/as de National Institute of Allergy and Infectious Diseases (6)
2024
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
The Lancet Microbe, Vol. 5, Núm. 6, pp. e559-e569
-
Monkeypox virus genomic accordion strategies
Nature Communications, Vol. 15, Núm. 1
2021
-
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
Clinical Infectious Diseases, Vol. 72, Núm. 11, pp. 2035-2041
2018
-
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2015
-
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study
PLoS ONE, Vol. 10, Núm. 10
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3